AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04068688 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early Start Denver Model (ESDM)
Description: Twelve one hour sessions, skill is introduced by Help is in your hands Community ESDM videos. Session skills include specific strategies caregivers can use to increase their child's attention to people and their child's communication; strategies to identify, create and use joint activity routines to engage with and teach their child; in addition to ways to use the ABCs of learning to teach their child new behaviors. Help is in your hands Community ESDM materials also provide video examples of other caregivers using the session skill with their child. The early childhood development practitioner then coaches the caregiver in the session skill, in at least two activities. The goal of coaching was to provide enough support for the caregiver to experience success in implementing the new skill with their child. Coaching is followed by caregiver reflection and a discussion of generalization of the new skill across various daily activities, using a daily activities visual aid.
Study NCT04068688 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth coaching
Description: The telehealth coaching intervention was informed by the Community-Early Start Denver Model (C-ESDM) materials. Twelve session-specific visuals with simple-text (for caregivers) and session scripts (for non-specialist coaches) were developed by the research team. Over 12, 1-hour asynchronous caregiver coaching sessions that are delivered by non-specialists, caregivers were coached in strategies to increase child attention to their social world, increase child communication, create and build joint activity routines, and understand and use the ABCs to support the development of new behaviors. The session itself being delivered via phone. Prior to the coaching session staff shared session materials with the family via WhatsApp. Prior to the session the caregiver shared a 6-min video of an interaction with their child. During the session, the caregiver and coach reviewed the video, and the caregiver completed a self-reflection checklist.
Study NCT03978884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Losartan 50Mg Tab
Description: Take 1 tab daily
Study NCT03978884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Losartan/Hydrochlorothiazide 50 Mg-12.5 Mg ORAL TABLET
Description: Take 1 tab daily
Study NCT03978884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Losartan/Hydrochlorothiazide 100 Mg-25 Mg ORAL TABLET
Description: Take 1 tab daily
Study NCT03978884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine 5mg
Description: Take 1 tablet daily
Study NCT05613699 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Exercise - Social Media
Description: The supervised online-social media exercise intervention took place once per week at a fixed, pre-scheduled time, via an online video conference platform. The training sessions lasted for 60 minutes and included a holistic workout with different focuses (e.g. resistance training for lower extremities, sensorimotor training, home-based endurance training). Patients were further recommended independent physical activity like walking or cycling, 1-2 times per week or to maintain the current volume of physical activity.
Study NCT05613699 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Exercise - App
Description: Exercise program in the online-app were personalized and focused on a combination of endurance and resistance training, 2-3 times a week, depending on patient's needs. Additional types of exercise (e.g. sensorimotor training) were added if therapy-related side effects were present. If necessary, exercise trainers conducted one introductory training session as video conference to check for exercise techniques and answer any individual questions.
Study NCT05613699 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Exercise - closed to patients residence
Description: The supervised exercise program close to patient's home was executed in a certified exercise facility of the network OnkoAktiv and supervised by special qualified exercise trainers. The weekly recommendation was to participate in a personalized in-person exercise program 1-2 per week, plus independent physical activity (or to maintain current level of physical activity)
Study NCT00930865 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bumetanide
Description: Tablets, Oral, 1 mg, Single Dose, 7 Days
Study NCT00930865 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin
Description: Tablets, Oral, 10 mg. Single Dose, 7 Days
Study NCT00978783 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Passy Muir Valve
Description: The Passy Muir Valve was fixed on the tracheostomy tube
Study NCT00978783 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Positive end expiratory pressure
Description: 5 cm H2O PEEP was adjusted
Study NCT04986670 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutritional Counseling
Description: Medical oncology providers will refer participants to oncology RDs for remotely delivered medical nutrition therapy counseling. For cohort 1, participants will receive nutrition counseling for 8 months. The counseling will be provided on a weekly basis during the first 6 months and every other week during the last 2 months (for cohort 1 only). For cohort 2, participants will receive nutrition counseling for 6 months. The ultimate frequency of nutrition counseling being provided to each participant will also be adjusted according to the participant's preference and needs.
Study NCT04986670 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medically Tailored Meals (MTMs)
Description: Medically tailored meals will be provided to participants in the intervention group for a total of 24 weeks for both cohorts. During the first 8 weeks of the intervention, 3 meals/day will be provided each week for a total of 168 meals per participant. It will be followed by less frequent meal provision during the subsequent 16 weeks following this schedule: 3 meals/day will be provided every other week for the next 8 weeks (a total of 84 meals per participant); and 3 meals/day will be provided every four weeks during the last 8 weeks (a total of 42 meals per participant). The number of meals provided to each participant may be adjusted according to participant's preference and needs.
Study NCT04986670 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition Prescription
Description: Oncology providers will advise participants with lung cancer to follow evidence-based nutrition recommendations using a Nutrition Prescription. The Nutrition Prescription aims to enhance providers' role in communicating basic nutrition advice to participants with lung cancer. It contains seven recommendations, adapted from the newly released Cancer Prevention Recommendations by WCRF/AICR with strong evidence-base.
Study NCT04986670 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutrition Assessment
Description: Oncology care providers will assess the nutritional status of patients with lung cancer using PG-SGA Short Form (the Scored Patient-Generated Subjective Global Assessment). PG-SGA is an interdisciplinary patient assessment in oncology and other chronic catabolic conditions. The short form contains four patient generated historical components (weight history, food intake symptoms, and activities and function).
Study NCT04986670 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition Toolkit
Description: Patients will receive a printed copy of a Nutrition Toolkit from providers. Evidence-based nutrition recommendations have been compiled for cancer survivors from 4 sources into a Nutrition Toolkit. The sources include: (1) AmericanCancer Society (ACS) Nutrition and Physical Activity Guidelines for Cancer Survivors; (2)World Cancer Research Fund / American Institute for Cancer Research (WFRF/AICR) Cancer Nutrition Guide; (3) National Cancer Institute (NCI) Eating Hints; and (4) National Comprehensive Cancer Network (NCCN) Guidelines for Cancer Survivors. The Nutrition Toolkit outlines topics about the impact of cancer treatment on dietary intake patterns and quality, strategies to manage treatment-related eating issues, maintaining a healthy weight post treatment, and evidence-based recommendations and practical. Nutrition Toolkit strategies for improving diet quality and maintaining an optimal weight for cancer survivors.
Study NCT04986670 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nutrition Toolkit
Description: Patients will receive a printed copy of a Nutrition Toolkit from providers. Evidence-based nutrition recommendations have been compiled for cancer survivors from 4 sources into a Nutrition Toolkit. The sources include: (1) AmericanCancer Society (ACS) Nutrition and Physical Activity Guidelines for Cancer Survivors; (2)World Cancer Research Fund / American Institute for Cancer Research (WFRF/AICR) Cancer Nutrition Guide; (3) National Cancer Institute (NCI) Eating Hints; and (4) National Comprehensive Cancer Network (NCCN) Guidelines for Cancer Survivors. The Nutrition Toolkit outlines topics about the impact of cancer treatment on dietary intake patterns and quality, strategies to manage treatment-related eating issues, maintaining a healthy weight post treatment, and evidence-based recommendations and practical. Nutrition Toolkit strategies for improving diet quality and maintaining an optimal weight for cancer survivors.
Study NCT04986670 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Monthly Emails
Description: Monthly emails will be sent to participants to encourage the use of the toolkit with healthy recipes and general nutrition information.
Study NCT04986670 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Monthly Emails
Description: Monthly emails will be sent to participants to encourage the use of the toolkit with healthy recipes and general nutrition information.
Study NCT01184859 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Desmopressin
Description: Desmopressin oral lyophilisate melt tablet, in either the 10, 25, 50, or 100 μg dosage, for sublingual administration
Study NCT00566956 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hydrosalpinx needle aspiration to arm 1
Description: For those assigned to Group I, the hydrosalpinx will be aspirated after all the eggs have been collected, under GA. Under ultrasound-guidance, the aspiration (egg collection) needle will be inserted into the hydrosalpinx and suction applied until no more fluid is obtained. If there are bilateral hydrosalpinges, the process is repeated on the opposite side. The hydrosalpinx fluid is discarded
Study NCT00769535 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Polymorphisms of HSP70 and TNF promoter
Description: To assess the relationship between clinical relevance and polymorphisms of HSP70 and tumor necrosis factor-alpha with PCR_RFLP
Study NCT00421824 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin, capecitabine
Description: OXA 130 D1 + Capecitabine 2000 / day D1-D14 for 4 cycles. After 10 weeks of rest, XELOX-RT regimen x 5 weeks followed by surgery
Study NCT00421824 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin, capecitabine
Description: XELOX-RT x 5 weeks followed by surgery and 4 cycles of adjuvant XELOX with the same scheme as arm A.
Study NCT01184859 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo melt tablet for sublingual administration
Study NCT04041661 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active tDCS plus gait training
Description: Participants in experimental group will accept Active tDCS which combined with treadmill
Study NCT04041661 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham tDCS plus gait training
Description: Participants in control group will accept Sham tDCS which combined with treadmill
Study NCT04037943 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Walnuts 30 grams
Description: Roasted walnuts without salt or sugar.
Study NCT04037943 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Walnuts 60 grams
Description: Roasted walnuts without salt or sugar.
Study NCT03683914 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dinoprostone 3Mg Vaginal Tablet
Description: 1 vaginal tablet of dinoprostone (3mg) (prostin® E2, Pharmacia \& Upjohn, Puurs, Belgium) inserted by the patient 12 hours before the scheduled office diagnostic hysteroscopy.
Study NCT03683914 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo vaginal tablet
Description: 1 vaginal tablet of placebo inserted by the patient 12 hours before the scheduled office diagnostic hysteroscopy.
Study NCT00985634 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LeGoo
Description: LeGoo internal vessel occluder. Usage (dose) as required and determined by surgeon.
Study NCT00985634 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Vessel loops
Study NCT05964556 — intervention group
Intervention type: OTHER
Intervention: Functional Movement Screen (FMS)
Description: FMS is an analysis system that evaluates muscle strength imbalance and functional performances on the dominant-non-dominant side in athletes. It aims to detect stability and mobility that can be ignored in the asymptomatic active population and athletes. It consists of 7 basic parameters determined by Gray Cook (Deep Squat, Hurdle Step, -In-line Lunge, Shoulder Mobility, Active Straight Leg Raise, Trunk Stability, Rotatory Stability). The athletes were evaluated after giving verbal instructions to the athletes about the head, trunk, knee and foot positions. For each parameter, the athletes were given points between 0-3 values. The total score was determined as 21 points. Completing the movement completely and without compensation was given 3 points, and 2 or 1 points were given according to the activation of the compensation mechanism and balance disorders. In case of any pain during or at the end of the movement in the evaluated parameter, 0 points were given to the athletes.
Study NCT05964556 — intervention group
Intervention type: OTHER
Intervention: Isokinetic Muscle Evulation of Knee Muscles
Description: The isokinetic knee flexor and extensor group muscle strengths of the athletes participating in the study were measured on the dominant and non-dominant sides. Measurements were performed with an ISOMED 2000 (D\&R Ferstl GmbH, Hemau, Germany) isokinetic measuring device. The test protocol was adjusted to be concentric/concentric. Measurements were made at angular velocities of 60°/sec and 180°/sec. At an angular speed of 60°/sec, the athlete was asked to perform 10 repetitions of voluntary knee flexion/extension at maximum strength. Then, after resting for 30 seconds, 30 repetitions of knee flexion/extension were performed at an angular velocity of 180°/sec. Before starting the test in both angular speeds, 3 repetitive attempts were made to learn the movement. The following parameters were evaluated at 60°/sec and 180°/sec angular speed.
Study NCT04701970 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: relining of mandibular complete denture
Description: Relining of mandibular dentures was performed by reducing one mm of the denture fitting surfaces and borders to make a right-angled border. apply two separate layers of Mucopren adhesive upon the vestibular surface of the mandibular denture and allow each layer to dry for about 40 seconds. then, the lower denture was inserted and molded in patient mouths; while biting in centric occlusion with the opposing maxillary complete dentures.
Study NCT01967719 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: mTHS 2.2
Description: Single use of mTHS 2.2
Study NCT01967719 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: mCC
Description: Single use of subject's own mCC
Study NCT01967719 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NNS
Description: Single administration of 1 mg of nicotine
Study NCT03562897 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ocoxin-Viusid
Description: Ocoxin-Viusid group (Experimental): Oral solution Ocoxin-Viusid (30 ml vials) were used at a rate of 60ml / day (1 vial every 12 hours), preferably administered after breakfast and dinner. The treatment will start a week before start Chemotheray treatment (CT) and, It will maintenance until 3 weeks after finished the last cycle of CT (3 cycles of CT of Carboplatin/Paclitaxel or Cisplatin/ Paclitaxel with neoadjuvant intent).
Study NCT03354897 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Torasemide 5Mg Tablet
Description: 16 weeks treatment
Study NCT00651937 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Melphalan
Description: 100 mg/m\^2 via a Central Venous Catheter (CVC) Over 15-20 Minutes on Days -3 and -2 prior to stem cell infusion.
Study NCT00651937 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stem Cell Infusion
Description: Stem Cell Infusion is Day 0.~Standard Dose (Arm 1) = Stem cell dose of between 4-6 x 10\^6 CD34/kg On Day 0~High Dose (Arm 2) = Stem cell dose of between 10-15 x 10\^6 CD34/kg On Day 0.
Study NCT00651937 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaires
Description: Beginning Visit 1, twice a week, paper and automated phone interview of symptoms and quality of life questionnaires.
Study NCT00651937 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Granulocyte-colony stimulating factor (G-CSF)
Description: 5 mcg/kg given subcutaneously (under the skin) on a daily basis for approximately 10 days.
Study NCT00651937 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Apheresis
Description: Collection of stem cells from blood collected either through CVC or from a vein in one arm.
Study NCT01314898 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3 mg PF-03882845
Description: 3 mg PF-03882845, single oral dose
Study NCT01314898 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10 mg PF-03882845
Description: 10 mg PF-03882845, single oral dose
Study NCT01314898 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 30 mg PF-03882845
Description: 30 mg PF-03882845, single oral dose
Study NCT01314898 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 100 mg PF-03882845
Description: 100 mg PF-03882845, single oral dose
Study NCT01314898 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spironolactone
Description: 100 mg spironolactone, single oral dose
Study NCT04739488 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inhaler training
Description: This training was given to both intervention groups. How the patients used their inhaler medication was evaluated. The steps to use the correct inhaler medication were taught sequentially. It was applied with the patient. At the end of the training, brochures prepared by the researchers were given to the patients.
Study NCT04739488 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breathing exercises
Description: This training was given only to the group that received breathing exercise and inhaler training.~Pursed lips breathing exercises were taught to the patients. Patients were asked to continue their breathing exercise for 10 minutes before using their inhaler medication.~Thus, it was evaluated whether breathing exercises performed before using inhaler drugs provided benefit on drug effectiveness.
Study NCT00260676 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: change ventilation
Description: reduction of tidal volume, increase of PEEP, recruiting maneuver, apnea test during CPAP
Study NCT01100892 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Once-daily insulin detemir
Description: Insulin detemir is a long-acting insulin analog. Starting dose 0.1 units/kg/day (titrated according to the results of home blood glucose monitoring).
Study NCT00814632 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-10004
Description: CC-10004 20 mg. twice a day for 12 weeks
Study NCT03022110 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endoscopic Ultrasound-guided Drainage
Description: Pancratic pseudocyst drainaged under the guide of Endoscopic Ultrasound
Study NCT03022110 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic Ultrasound-guided Drainage
Description: Pancratic pseudocyst drainaged under the guide of Endoscopic Ultrasound
Study NCT01304108 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VTE-P Tollgate
Description: Add VTE-P tollgate order set that requires a decision regarding VTE-P for every patient admitted or transferred in our hospital system
Study NCT01304108 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: BLAZE Pop up
Description: Develop and deploy a rules-based popup that reminds prescribers interfacing with the orders system when a patient does not have an active VTE-P plan.
Study NCT01304108 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: No addition to the baseline system for care
Study NCT02493881 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: intraoperative neuromonitoring
Description: NIM-Response 3.0 Intraoperative Neuromonitoring System (Medtronic Xomed, Jacksonville, FL, USA) was used to record the EMG amplitude signal for the anterior and/or posterior branches of recurrent laryngeal nerves (RLNs).
Study NCT00549861 — intervention group
Intervention type: PROCEDURE
Group type: NO_INTERVENTION
Intervention: Cardiac Magnetic Resonance study
Description: Cardiac MRI study
Study NCT00729053 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IMO-2055
Description: immunostimulatory oligonucleotide
Study NCT03140878 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: LGG
Description: LGG is dissolved in water and consumed at one occasion (either at visit 2 or 3)
Study NCT03140878 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo is dissolved in water and consumed at one occasion (either at visit 2 or 3)